Mirum Pharmaceuticals Ratios (2020-2025) | MIRM

Ratios Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin 84.24%81.83%78.57%64.03%74.24%74.03%76.98%77.09%79.37%81.67%80.80%
EBT Margin 11,136.72%1,494.44%-398.94%-941.98%1,825.75%-283.86%-191.56%-190.06%-130.05%-94.72%-196.61%-48.90%-50.94%-35.62%-30.82%-15.37%-24.51%-12.23%-4.27%1.99%
EBIT Margin 11,030.15%1,408.25%-340.01%-856.48%-1,452.36%-253.92%-179.83%-175.09%-122.41%-85.92%-64.73%-52.69%-46.85%-38.24%-31.12%-14.03%-24.36%-13.61%-3.90%1.96%
EBITDA Margin 11,030.15%1,408.25%-340.01%-856.48%-1,452.36%-253.92%-179.83%-175.09%-122.41%-85.92%-64.73%-52.69%-46.85%-38.24%-31.12%-14.03%-24.36%-13.61%-3.90%1.96%
Operating Margin 11,030.15%1,408.25%-340.01%-856.48%-1,452.36%-253.92%-179.83%-175.09%-122.41%-85.92%-64.73%-52.69%-46.85%-38.24%-31.12%-14.03%-24.36%-13.61%-3.90%1.96%
Net Margin 11,137.31%1,494.59%-399.04%-942.16%1,825.37%-283.94%-209.37%-190.13%-130.55%-95.35%-197.45%-49.42%-51.27%-36.52%-31.64%-15.75%-23.93%-13.15%-4.59%2.18%
FCF Margin 10,837.91%745.73%-365.45%-684.40%-1,056.41%-307.70%-115.47%-138.68%-123.67%-59.54%-46.40%-38.18%-23.89%21.96%-5.88%4.21%-5.12%-1.79%9.32%29.69%
Efficiency
Inventory Average 1.55M3.05M5.73M6.25M6.09M7.56M15.38M22.28M21.96M21.02M21.02M22.00M22.41M22.68M23.48M
Assets Average 164.28M148.82M191.36M231.55M234.95M241.42M264.91M286.40M287.69M330.79M358.63M343.22M388.56M547.12M648.63M649.29M656.36M664.32M669.32M680.50M708.03M755.47M
Equity Average 146.16M128.23M146.18M152.99M114.81M76.07M88.30M114.57M109.81M139.99M155.67M141.59M109.88M173.85M258.88M241.64M231.80M230.51M228.83M229.45M244.21M273.60M
Invested Capital 156.12M136.21M120.25M173.36M134.81M97.94M57.24M122.21M110.93M112.45M171.06M143.13M142.24M78.61M269.08M248.67M234.60M228.99M232.02M225.64M233.26M255.16M292.05M
Asset Utilization Ratio 0.050.060.110.130.160.210.280.300.260.290.340.400.460.500.560.610.62
Leverage & Solvency
Interest Coverage Ratio -110.30-14.08-7.83-7.56-12.10-8.67-8.11-8.28-7.84-6.40-6.51-7.04-9.15-7.40-6.79-3.54-6.77-4.22-1.390.72
Debt to Equity 0.010.010.020.020.020.020.020.010.010.01
Debt Ratio 0.010.000.010.000.010.010.010.000.000.00
Equity Ratio 0.900.870.850.710.600.390.240.410.390.370.460.400.420.180.410.380.360.350.350.340.340.350.37
Times Interest Earned -110.30-14.08-7.83-7.56-12.10-8.67-8.11-8.28-7.84-6.40-6.51-7.04-9.15-7.40-6.79-3.54-6.77-4.22-1.390.72
Valuation
Enterprise Value 101.86M278.50M270.77M217.20M389.81M155.83M268.69M232.14M365.17M324.83M253.23M467.25M779.51M653.93M904.19M1,089.73M877.88M1,333.11M1,576.14M1,704.67M1,930.42M2,216.27M3,307.37M
Market Capitalization 355.46M494.09M489.44M449.02M602.92M526.54M607.88M488.68M698.70M619.52M688.11M718.97M911.58M983.88M1,210.22M1,376.05M1,180.72M1,611.48M1,860.58M1,984.99M2,208.09M2,520.82M3,682.92M
Return Ratios
Return on Sales -14.56%-5.35%-2.20%-1.39%-0.80%-1.76%-1.35%-1.52%-1.13%-0.88%-0.71%-0.41%-0.33%-0.26%-0.20%-0.14%-0.09%
Return on Capital Employed -0.60%-0.66%-0.70%-0.86%-0.78%-0.63%-0.63%-0.51%-0.45%-0.43%-0.36%-0.23%-0.19%-0.20%-0.20%-0.17%-0.16%-0.14%-0.10%-0.07%
Return on Invested Capital -1.22%-0.87%-0.80%-0.84%
Return on Assets -0.54%-0.57%-0.65%-0.74%-0.32%-0.25%-0.19%-0.13%-0.38%-0.38%-0.45%-0.30%-0.25%-0.24%-0.17%-0.15%-0.13%-0.11%-0.08%-0.05%
Return on Equity -0.71%-0.87%-1.33%-2.35%-0.95%-0.61%-0.49%-0.30%-0.87%-0.91%-1.60%-0.94%-0.63%-0.66%-0.47%-0.43%-0.38%-0.34%-0.24%-0.15%